FPW
TMO icon

Fairvoy Private Wealth’s Thermo Fisher Scientific TMO Stock Holding History

Fairvoy Private Wealth’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-400
Closed -$232K – 223
2025
Q4 		$232K Buy
+400
New +$226K 0.05% 175
2025
Q2 		– Sell
-5,083
Closed -$2.53M – 189
2025
Q1 		$2.53M Buy
5,083
+667
+15% +$361K 0.7% 41
2024
Q4 		$2.3M Buy
+4,416
New +$2.43M 0.61% 49

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fairvoy Private Wealth's TMO Position: Q1 2026 in Review

Fairvoy Private Wealth sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 400 shares — an estimated $232K sold.

Fairvoy Private Wealth first reported a position in TMO in Q4 2024 and held it in 3 quarters. The position peaked at $2.53M in Q1 2025. 2,600 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Fairvoy Private Wealth reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • Fairvoy Private Wealth sold 400 Thermo Fisher Scientific shares in Q1 2026, an estimated $232K.
  • Fairvoy Private Wealth first reported a position in Thermo Fisher Scientific in Q4 2024 and held it in 3 quarters.
  • Fairvoy Private Wealth's Thermo Fisher Scientific position peaked at $2.53M in Q1 2025.
  • 2,600 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Fairvoy Private Wealth's 13F filing for Q1 2026, filed 20 Apr 2026.